In addition to transcriptional modification, RPP30 was positively correlated with the WNT signaling pathway (pro-cancer) and negatively correlated with several drug metabolism pathways (cytochrome p450 and ABC transporters) (Figure 5C). The gene discussed is RPP30; the disease is cancer.